IFNA1 and systemic sclerosis: Increased plasma levels of type I, II, and III IFN were noted in SSc-PAH patients, and, as expected, IFN-stimulated products, interferon γ inducible protein (IP10), and ET-1 were also elevated in SSc-PAH patients.